Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety, Pharmacokinetics, and Pharmacodynamics of MTX-101 in Healthy Adults and Patients

NCT06324604 is registered in ClinicalTrials.gov with Mozart Therapeutics Australia Pty Ltd as lead sponsor.

NCT NCT06324604
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06324604 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety, Pharmacokinetics, and Pharmacodynamics of MTX-101 in Healthy Adults and Patients
Lead sponsor
Mozart Therapeutics Australia Pty Ltd
Phase
Phase 1
Overall status
Recruiting
Start date
June 13, 2024
Completion date
June 30, 2027
Enrollment
96 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers, type 1 diabetes